ArticleTherapeutic advances in medical oncology2020

A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial.

Francesca Simionato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.